Trump order signals shake-up in drug pricing innovation through Medicare and Medicaid
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
RFK JR. grilled on Medicare: What is Medicare Part A, Medicare Part B and Medicaid? What are they?
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
CNN on MSN13d
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
JD Supra1h
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
Does Medicare cover ketamine infusions for mental health conditions?
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
WXII 12 NEWS13d
Medicare to cut costs on 25 drugs, including Wegovy and Ozempic
Popular weight loss drugs like ... been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said ...
USA Today13d
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration announced Friday that Medicare will negotiate discounts with pharmaceutical companies on 15 drugs prescribed to treat cancer, diabetes and asthma. Those drugs are ...
CNN13d
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Medicare spent $14.4 billion on Ozempic ... Ozempic, which the US Food and Drug Administration has approved to treat diabetes, and Wegovy, which is approved for weight loss and the prevention ...